In the post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT), a US trial comparing blood pressure targets in 9361 persons without diabetes, elevated baseline level of Hs-cTnT was found positively associated with all-cause mortality, heart failure, and composite adverse severe events [20, 21]. Here, TNNT2 is linked to heart failure.